Laurus Labs has announced that the USFDA completed inspection of the formulations manufacturing facility Unit-2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh.
Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
Through the new agreements, Cristal Therapeutics and McSAF will gain access to Lonza’s integrated bioconjugates offering and will be able to leverage Lonza’s expertise in developing and manufacturing bioconjugates
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
Collaboration to implement AbTis’ AbClick platform into Lonza’s bioconjugation toolbox
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
Subscribe To Our Newsletter & Stay Updated
